THE DEFINITIVE GUIDE TO PRESCRIPTION FOR FENTANYL PATCHES

elranatamab will raise the amount or result of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Elranatamab causes cytokine launch syndrome (CRS) which could suppress action of CYP enzymes, leading to improved exposure of CYP substrates.fentanyl transdermal and protriptyline equally increase sedati